How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...
For the past decade, we’ve been sold a seductive vision: the “smart city.” Gleaming control rooms, traffic lights that talk ...
Investor's Business Daily on MSN
AI stocks: Will self-improving models decide who wins superintelligence race?
Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.
Alongside this rapid progress, an equally ambitious effort has emerged to construct ethical frameworks for intelligent ...
Amazon Mechanical Turk shutdown ends 21 years of invisible labor that powered the AI training industry, as AWS closes the ...
OpenAI has talked about how having an automated AI researcher was on its roadmap, and it’s shown the first glimpses of that ...
Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...
Abstract: By using in situ health information, many existing studies for online remaining useful life (RUL) prediction adopt a stochastic process-based degradation model and a computation-intensive ...
Microsoft Research conducts fundamental science and technology research across a spectrum of research areas. With labs around the globe we pursue breakthroughs across the computing and AI stack to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results